Rebeca Domingo

Rebeca Domingo

Auto-generated profile, based on publicly available information

Rebeca Domingo

Institut Clínic Cardiovascular (ICCV) Hospital Clínic de Barcelona Universitat de Barcelona Barcelona Catalonia Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2026 in Circulation
Verified
Journal Article
Open access
IRIvo Roca-Luque
Ivo Roca-Luque
PGPaz Garre
Paz Garre
SVSara Vázquez-Calvo
Sara Vázquez-Calvo
JPJosé Tomás Tomas Ortiz Pérez
José Tomás Tomas Ortiz Pérez
SPSusana Prat-González
Susana Prat-González
APAndreu Porta-Sánchez
Andreu Porta-Sánchez
BACKGROUND: Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is useful for identifying ventricular tachycardia (VT) substrate in patients with structural heart disease. While preprocedural LGE-CMR is widely used for planning, the role of postprocedural LGE-CMR in evaluating VT ablation success and long-term scar evolution has been less explored. This study aimed to prospectively and systematically assess the long-term evolution of scar and ablation lesions using serial postablation LGE-CMR with long-term follow-up. METHODS: This prospective study included 51 patients (mean age, 65.2±9.8 years; men, 95.8%; ischemic heart disease, 83%; left ventricular ejection fraction, 34.5±10.4%) undergoing their first substrate-based VT ablation between March 2019 and July 2020. Preprocedural LGE-CMR and 2 postprocedural scans at 3 to 6 months (CMR-1) and 18 to 24 months (CMR-2) were performed. Scar characteristics, including core scar, border zone, and conducting channels, were analyzed. VT recurrence was monitored, and factors associated with recurrence were evaluated using a Cox proportional hazards model. A Kaplan-Meier curve was used to represent the VT-free survival function. RESULTS: Core scar mass increased significantly from baseline to CMR-1 (12.2±1.5 to 19.8±1.6 g, P <0.01) and remained stable at CMR-2. In contrast, the border zone decreased significantly over time (pre, 25.3±1.8 g; CMR-1, 20.8±2.0 g; CMR-2, 16.7±2.1 g; P <0.01). A significant decrease in conducting channels was noted after ablation and persisted at CMR-2 (pre, mean 2.4±0.2/median 2 [interquartile range, 1–3]; CMR-1, mean 1.4±0.2/median 1 [interquartile range, 0–1]; CMR-2, mean 1.6±1.0/median 1 [interquartile range, 0–1]; P <0.001). VT recurrence occurred in 29.4% of patients during a median follow-up of 3.1 years. The number of conducting channels at CMR-1 and their relative reduction from baseline were related to VT recurrence. The persistence of 2 or more conducting channels at CMR-1 was associated with a higher recurrence rate: 75.6 versus 19.5% (hazard ratio [HR]; 4.1; 95% CI, 2.4–12.1; P =0.012). Evidence of favorable left ventricular remodeling was observed, with a significant reduction in left ventricular volume at CMR-2 (131.8±8.6 mL; CMR-1, 156.7±8.1 mL and 160.8±7.6 mL at baseline <0.01). CONCLUSIONS: Postablation LGE-CMR reveals durable changes in scar characteristics, with early scar evaluation at 3 to 6 months strongly associated with long-term VT recurrence. The reduction in scar heterogeneity and conducting channels is sustained over time, underscoring the usefulness of LGE-CMR for assessing ablation success. Additionally, VT ablation appeared to be associated with favorable reverse remodeling, highlighting potential benefits beyond arrhythmia control. These findings support the use of LGE-CMR for personalized management following VT ablation.

1 March 2026 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
ACAlba Cano-Valls
Alba Cano-Valls
MMMª Antonia Martinez
Mª Antonia Martinez
ECEsther Carro-Fernández
Esther Carro-Fernández
MNMireia Niebla
Mireia Niebla
RDRebeca Domingo
Rebeca Domingo
EGEduard Guasch
Eduard Guasch
BACKGROUND: Atrial fibrillation (AF) is associated with reduced quality of life and frequent hospitalizations. Integrated nurse-led care (NLC) has proven beneficial in unselected AF patients, but evidence specific to patients undergoing catheter ablation is limited. We aimed to assess the impact of a structured nurse-led intervention in patients undergoing first-time AF ablation. METHODS: NURSECAT-AF was a single-center prospective randomized clinical trial comparing usual care with NLC, which incorporated an AF educational program, peri-procedural support, and risk factor management. Consecutive patients without heart failure referred for first-time AF ablation were randomized to NLC or usual care. NLC visits were scheduled at 15 days preablation, 15 days, and 6 months postablation. The primary end point was quality of life at 12 months postablation using the arrhythmia-specific scale in tachycardia and arrhythmia. Secondary outcomes included arrhythmia recurrence, readmissions and emergency visits, and symptom burden at 1 year and AF knowledge and satisfaction at 3 months. RESULTS: Of 116 patients screened, 66 were randomized (33 per group; mean age 63±10 years; 67% male). At 12 months, the NLC group showed statistically significant better quality of life (baseline-adjusted arrhythmia-specific scale in tachycardia and arrhythmia difference +4 points [95% CI, 1.8–6.3]; P =0.0007) than usual care, and presented with less arrhythmia recurrences (odds ratio, 0.2 [95% CI, 0.05–0.78]) and emergency visits (odds ratio, 0.2 [95% CI, 0.06–0.66]). Patients assigned to NLC also presented with a lower symptom burden, higher satisfaction, and greater disease knowledge. Risk factor profile was improved in the NLC group, with higher rates of smoking cessation, engagement in regular physical activity, and weight optimization. Nurse-led management enabled more frequently diagnosing obstructive sleep apnea. CONCLUSIONS: Nurse-led, integrated care for patients undergoing AF ablation improves the quality of life, clinical outcomes, and risk factor management at 1 year postprocedure. These findings support the incorporation of structured nurse-led interventions in the peri-ablation care pathway. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05333445.

16 September 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Open access
PDF file
MPMargarida Pujol‐Lopez
Margarida Pujol‐Lopez
MRMariona Regany‐Closa
Mariona Regany‐Closa
EGEduard Guasch
Eduard Guasch
PGPaz Garre
Paz Garre
MNMireia Niebla
Mireia Niebla
LMLluís Mont
Lluís Mont
Background: Optimization of biventricular pacing for cardiac resynchronization therapy (CRT) with fusion (fusion‐optimized intervals method) has been shown to improve left ventricular remodeling. However, information on programming the atrioventricular (AV) interval during left bundle branch pacing (LBBP) is scarce. Objective: Assess with electrocardiographic imaging (ECGI) the electrical benefit of optimization of the AV interval during LBBP. Methods: Retrospective analysis of prospectively collected data. Pilot study including patients who received LBBP with CRT indication, normal AV conduction, sinus rhythm, and left bundle branch block. ECGI was used to obtain non‐invasive activation maps, ventricular activation times, and QRS widths during the optimization of the AV interval. Results: A total of 10 patients who received LBBP were included. Median age was 62 years (57–74 years), 40% were women, 20% had ischemic cardiomyopathy, and baseline LVEF was 29% (23%–36%). The baseline median QRS duration was 178 ms (168–187 ms), with a left ventricular activation time (LVAT) of 99 ms (90–109 ms), a right ventricular activation time (RVAT) of 42 ms (34–71 ms), and a total ventricular activation time (TAT) of 111 ms (105–131 ms). A non‐tailored AV programming showed a QRS measured from intrinsic deflection of 142 ms (137–149 ms); when a tailored AV was programmed, the median QRS decreased to 124 ms (116–130 ms). Ventricular activation times showed shortening with a tailored approach. Conclusion: AV interval adjustment during left bundle branch pacing may result in better resynchronization.

2 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ACAlba Cano-Valls
Alba Cano-Valls
MMMª Antonia Martinez
Mª Antonia Martinez
ECEsther Carro-Fernández
Esther Carro-Fernández
MNMireia Niebla-Bellido
Mireia Niebla-Bellido
RDRebeca Domingo-Criado
Rebeca Domingo-Criado
EGEduard Guasch
Eduard Guasch
Background: Atrial fibrillation (AF) is associated with reduced quality of life and frequent hospitalizations. Integrated nurse-led care has proven beneficial in unselected AF patients, but evidence specific to patients undergoing catheter ablation is limited. We aimed to assess the impact of a structured nurse-led intervention in patients undergoing first-time AF ablation. Methods: NURSECAT-AF was a single-center prospective randomized clinical trial comparing usual care (UC) with a nurse-led peri-ablation care (NLC) which incorporated an educational program on AF, peri-procedural support, and risk factor management. Consecutive patients without heart failure referred for first-time AF ablation were randomized to UC or NLC. Visits in NLC were scheduled at 15 days pre-ablation, and 15 days, 3 months and 6 months post-ablation. The primary endpoint was quality of life at 12 months post-ablation using the Arrhythmia-Specific Scale in Tachycardia and Arrhythmia (ASTA). Secondary outcomes included arrhythmia recurrence, readmissions and emergency visits, and symptom burden at one year, and AF knowledge and satisfaction at 3 months. Results: Of 116 patients screened, 66 were randomized (33 per group; mean age 63±10 years; 67% male). At 12 months, the NLC group showed significantly better quality of life (baseline-adjusted ASTA difference +4 points [95%CI 1.8-6.3], p=0.007) than UC, and presented with less arrhythmia recurrences (OR 0.2 [95%CI 0.05-0.78]) and emergency visits (OR 0.2 [95%CI 0.06-0.66]). Patients assigned to NLC also presented with a lower symptom burden, higher satisfaction and greater disease knowledge. Risk factor profile was improved in the NLC group, with higher rates of smoking cessation, engagement in regular physical activity, and weight optimization. Nurse-led management enabled more frequently diagnosing obstructive sleep apnea. Conclusion: Nurse-led, integrated care for patients undergoing AF ablation improves the quality of life, clinical outcomes and risk factor management at one year post-procedure. These findings support the incorporation of structured nurse-led interventions in the peri-ablation care pathway. Clinical Trial Registration: NCT05333445. https://clinicaltrials.gov/study/NCT05333445?term=NCT05333445&rank=1 GRAPHICAL (Annex B) Clinical Perspective: What is known?: Nurse-coordinated, integrated care pathways in patients with chronic conditions, including atrial fibrillation (AF), have been shown to improve patient-reported quality of life and to reduce all-cause and cardiovascular mortality. Atrial fibrillation ablation effectively decreases arrhythmic burden and enhances quality of life; nonetheless, recurrences remain common, and many patients continue to experience symptoms and diminished functional status. The role of periprocedural nurse-led management remains unknown. What this study adds?: In a randomized controlled trial, implementation of a periprocedural, nurse-led care model significantly improved quality of life in patients undergoing AF ablation, as assessed by validated symptom and well-being instruments. At one year post-ablation, the incidence of AF recurrence is reduced in the cohort receiving nurse-led care, an effect likely mediated by superior optimization of cardiovascular risk factors achieved through targeted nurse intervention. A comprehensive, nurse-delivered strategy—comprising patient education, systematic preparation for ablation, and proactive management of modifiable arrhythmia risk factors—confers meaningful clinical benefit in the management of AF.